"The greatest wealth is health."         - Virgil

      Advertisement

Our Experts answered these questions:

My wife has arthritis,quite severe. if she sustains a bruise or a cut the results last for weeks or even months. she bruises badly with the slightest...
I was up last night having to use the bathroom with diarrhea for about an hour. This morning i woke up and i felt like i was going to throw up and i h...
Do You Have a Health Question? Ask Our Experts!

Vaccine Safety

Menu

• Home
• Ask our Experts about ATARAX
• Ask Community about ATARAX
• ATARAX Usage
• Patients Wiki
• Share Your Health Story
• Take a Survey
• Health Blogs

More Resources

• Federal Food and Drug Administration
• Hospital Quality Reports
• Home Care Quality

ATARAX Safety Questions, ATARAX Answers

More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about ATARAX. Our extensive database of ATARAX adverse events and ATARAX warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements

Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about ATARAX

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet

Type your question here

 letters left

ATARAX Safety Reports

Total ATARAX reports: 182.
ATARAX FDA safety alerts: No.
Reported deaths: 19    Reported hospitalizations: 88.
Take ATARAX Side Effects Survey or Share Your ATARAX Story. ATARAX Usage.

Showing 1-75 of 182 Next >

Physician from FRANCE reported ATARAX problem on June 13, 2006. Female patient was diagnosed with tachycardia and was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: anaemia, ecchymosis, erythroblastosis, foetal disorder, foetal distress syndrome, hypoxia, induced labour. ATARAX dosage: 25 MG, ORAL. During the same period patient was treated with ELEVIT PRONATAL, FERROUS SULPHATE, MAGNESIUM, UVEDOSE, SALBUTAMOL. Patient died.

ATARAX problem was reported by a Pharmacist from MONACO on June 19, 2006. Female patient, 74 years of age, was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: agitation, respiratory depression. ATARAX dosage: unknown. Patient was hospitalized. Patient died.

Physician from FRANCE reported ATARAX problem on June 13, 2006. Female patient was diagnosed with tachycardia and was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: amniotic cavity disorder, anaemia, hypoxia, placental disorder. ATARAX dosage: 25 MG, ORAL. During the same period patient was treated with ELEVIT PRONATAL, FERROUS SULPHATE, MAGNESIUM, COLECALCIFEROL, SALBUTAMOL. Patient died.

ATARAX problem was reported by a Health Professional from JAPAN on June 08, 2006. Male patient, 19 years of age, was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: alcohol use, suicide attempt, vomiting. ATARAX dosage: unknown. During the same period patient was treated with ALCOHOL. Patient recovered.

Health Professional from JAPAN reported ATARAX problem on June 28, 2006. Female patient, 37 years of age, was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: injection site necrosis. ATARAX dosage: 50 MG, INTRAMUSCULAR. During the same period patient was treated with PENTAZOCINE LACTATE, ATROPINE. Patient recovered.

ATARAX problem was reported by a Health Professional from JAPAN on June 28, 2006. Male patient, 34 years of age, weighting 121.3 lb, was diagnosed with preoperative care and was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: injection site erythema, injection site necrosis, injection site swelling, injection site ulcer. ATARAX dosage: 50 MG (ONCE), INTRAMUSCULAR. During the same period patient was treated with PURSENNID, MAGCOROL, LAXOBERON, GLYCERIN, CEFAZOLIN. Patient recovered.

Health Professional from FRANCE reported ATARAX problem on June 28, 2006. Male patient, 31 years of age, was diagnosed with ill-defined disorder and was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: abdominal tenderness, arrhythmia, atrial fibrillation, balance disorder, body temperature increased, cardiac arrest, confusional state, constipation, disorientation. ATARAX dosage: 200 MG (1 D), ORAL. During the same period patient was treated with METHADONE, CLONAZEPAM, BACTRIM. Patient died on 02/13/2006.

ATARAX problem was reported by a Consumer or non-health professional from FRANCE on July 03, 2006. Female patient, 69 years of age, was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: condition aggravated, dermatitis exfoliative, eosinophilia, intertrigo, pruritus. ATARAX dosage: unknown. During the same period patient was treated with RANITIDINE, VISIPAQUE, PLAVIX, ASPEGIC, INDAPAMIDE, BISOPROLOL FUMARATE, RAMIPRIL. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported ATARAX problem on July 10, 2006. Male patient, 22 years of age, was diagnosed with anxiety and was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: phlebitis. ATARAX dosage: 25 MG (1 IN 1 D), INTRAVENOUS. Patient recovered.

ATARAX problem was reported by a Consumer or non-health professional from FRANCE on July 12, 2006. Female patient, 85 years of age, was diagnosed with abnormal behaviour and was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: blood sodium increased, dehydration, disturbance in attention, renal failure, somnolence, urinary tract infection. ATARAX dosage: 10MG (DAILY). During the same period patient was treated with PRAZEPAM, IMOVANE, MIRTAZAPINE, POTASSIUM CHLORIDE, FUNGIZONE. Patient was hospitalized. Patient recovered.

Health Professional from FRANCE reported ATARAX problem on July 10, 2006. Female patient, 90 years of age, was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: agitation, red blood cell count abnormal, urinary retention. ATARAX dosage: unknown. Patient was hospitalized. Patient recovered.

ATARAX problem was reported by a Consumer or non-health professional from FRANCE on July 10, 2006. Male patient, 72 years of age, was diagnosed with anxiety, cardiac failure, atrial fibrillation, atrial flutter, sleep disorder and was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: lichen planus, toxic skin eruption. ATARAX dosage: unknown. During the same period patient was treated with LASIX, DIGOXIN, PREVISCAN, NOCTRAN, CODARONE. Patient was hospitalized. Patient recovered.

Pharmacist from JAPAN reported ATARAX problem on July 13, 2006. Female patient was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased. ATARAX dosage: unknown. During the same period patient was treated with DEPAKENE. Patient recovered.

ATARAX problem was reported by a Consumer or non-health professional from FRANCE on July 17, 2006. Female patient was diagnosed with cholestasis of pregnancy and was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: assisted delivery, blood glucose decreased, extrasystoles, feeding disorder neonatal, hypotonia neonatal, neonatal oversedation. ATARAX dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported ATARAX problem on July 24, 2006. Male patient, 34 years of age, weighting 121.3 lb, was diagnosed with preoperative care and was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: epidermal necrosis, injection site erythema, injection site swelling, injection site ulcer. ATARAX dosage: 50 MG (ONCE), INTRAMUSCULAR. During the same period patient was treated with PURSENNID, MAGCOROL, LAXOBERON, GLYCERIN, CEFAZOLIN, SEVOFLURANE, MUSCULAX, DIPRIVAN. Patient was hospitalized. Patient recovered.

ATARAX problem was reported by a Physician from JAPAN on July 24, 2006. Male patient, 22 years of age, was diagnosed with anxiety and was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: phlebitis. ATARAX dosage: 25 MG (1 IN 1 D), INTRAVENOUS. Patient recovered.

Health Professional from JAPAN reported ATARAX problem on July 24, 2006. Female patient, 45 years of age, was diagnosed with sedation and was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: injection site necrosis. ATARAX dosage: 50 MG, INTRAMUSCULAR. During the same period patient was treated with PENTAZOCINE LACTATE. Patient recovered.

ATARAX problem was reported by a Health Professional from JAPAN on July 24, 2006. Female patient, 37 years of age, was diagnosed with induction of anaesthesia and was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: injection site necrosis. ATARAX dosage: 50 MG, INTRAMUSCULAR. During the same period patient was treated with PENTAZOCINE LACTATE, ATROPINE. Patient recovered.

Health Professional from JAPAN reported ATARAX problem on July 24, 2006. Female patient, 15 years of age, was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: suicide attempt. ATARAX dosage: unknown. Patient recovered.

ATARAX problem was reported by a Consumer or non-health professional from JAPAN on July 26, 2006. Female patient, 29 years of age, was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: dizziness, feeling hot, intentional overdose, suicide attempt, vomiting. ATARAX dosage: unknown. Patient recovered.

Pharmacist from JAPAN reported ATARAX problem on July 27, 2006. Female patient, 45 years of age, was diagnosed with sedation and was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: injection site necrosis. ATARAX dosage: 50 MG, INTRAMUSCULAR. During the same period patient was treated with PENTAZOCINE LACTATE. Patient recovered.

ATARAX problem was reported by a Pharmacist from JAPAN on July 27, 2006. Female patient, 37 years of age, was diagnosed with induction of anaesthesia and was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: injection site necrosis. ATARAX dosage: 50 MG, INTRAMUSCULAR. During the same period patient was treated with PENTAZOCINE LACTATE, ATROPINE. Patient recovered.

Health Professional from SWEDEN reported ATARAX problem on July 31, 2006. Female patient, 21 years of age, was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: alcohol use, mydriasis, vomiting. ATARAX dosage: unknown. During the same period patient was treated with DIAZEPAM, TREO COMP, IBUPROFEN, FLUOXETINE, ALCOHOL. Patient was hospitalized. Patient recovered.

ATARAX problem was reported by a Pharmacist from JAPAN on July 31, 2006. Female patient, 16 years of age, was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: injection site ulcer. ATARAX dosage: unknown. During the same period patient was treated with ATROPINE SULPHATE. Patient recovered.

Health Professional from FRANCE reported ATARAX problem on July 28, 2006. Female patient, 22 years of age, was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: hyperthermia malignant, sinus tachycardia. ATARAX dosage: unknown. Patient was hospitalized. Patient recovered.

ATARAX problem was reported by a Physician from GERMANY on Aug 03, 2006. Female patient, 35 years of age, was diagnosed with urticaria, pain and was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: somnolence, trismus, urticaria. ATARAX dosage: 25 MG, ORAL. During the same period patient was treated with LEVOCETIRIZINE DIHYDROCHLORIDE, TRAMADOL, PANTOPRAZOLE. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported ATARAX problem on Aug 08, 2006. Female patient, 16 years of age, was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: injection site ulcer. ATARAX dosage: unknown. During the same period patient was treated with ATROPINE SULPHATE. Patient recovered.

ATARAX problem was reported by a Consumer or non-health professional from FRANCE on Aug 04, 2006. Male patient, 69 years of age, was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: rash. ATARAX dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. During the same period patient was treated with PREDNISOLONE, DESLORATADINE. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported ATARAX problem on Aug 10, 2006. Female patient, 16 years of age, was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: injection site ulcer. ATARAX dosage: 25 MG INTRAMUSCULAR. During the same period patient was treated with ATROPINE SULPHATE, ATROPINE SULPHATE. Patient recovered.

ATARAX problem was reported by a Physician from FRANCE on Aug 08, 2006. Female patient, 57 years of age, was diagnosed with prurigo, constipation, depression and was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: dyskinesia, muscular weakness, peripheral sensory neuropathy, tendonitis. ATARAX dosage: 4 DF (100 MG, DAILY) ORAL. During the same period patient was treated with THALIDOMIDE, MODANE, DOXEPIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Health Professional from SWEDEN reported ATARAX problem on Aug 14, 2006. Female patient, 26 years of age, was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: communication disorder, loss of consciousness. ATARAX dosage: unknown. Patient was hospitalized. Patient recovered.

ATARAX problem was reported by a Health Professional from FRANCE on Aug 22, 2006. Female patient, 78 years of age, was diagnosed with femur fracture, melaena, pyrexia and was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: dementia, fall, femur fracture, hepatitis cholestatic, overdose. ATARAX dosage: 25 MG (25 MG, 1 IN 1 D), ORAL. During the same period patient was treated with KETOPROFEN, ACETAMINOPHEN, PANTOPRAZOLE, FOLIC ACID, AMOXICILLIN, EQUANIL, VITAMIN B1, VITAMIN B6. Patient was hospitalized. Patient recovered.

Health Professional from FRANCE reported ATARAX problem on Aug 23, 2006. Female patient, 82 years of age, was diagnosed with urticaria, essential hypertension, vertigo and was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, anorexia, cholestasis, hepatitis, hypercalcaemia, hypokalaemia, jaundice, nausea, pruritus. ATARAX dosage: unknown. During the same period patient was treated with ALDACTONE, MECLIZINE, PREDNISONE, IBUPROFEN, TINSET, SECALIP, TIORFAN. Patient was hospitalized. Patient recovered.

ATARAX problem was reported by a Health Professional from FRANCE on Aug 22, 2006. Female patient, 78 years of age, was diagnosed with femur fracture, melaena, lung disorder, pyrexia and was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: fall, femur fracture, hepatitis cholestatic, lung disorder, overdose, pyrexia. ATARAX dosage: 25 MG (25 MG, 1 IN 1 D),ORAL. During the same period patient was treated with KETOPROFEN, ACETAMINOPHEN, PANTOPRAZOLE, FOLIC ACID, AMOXICILLIN, EQUANIL, VITAMIN B6. Patient was hospitalized. Patient recovered.

Health Professional from FRANCE reported ATARAX problem on Aug 23, 2006. Female patient, 82 years of age, was diagnosed with urticaria, essential hypertension, vertigo and was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, anorexia, cholestasis, hepatitis, hypercalcaemia, hypokalaemia, jaundice, nausea, ocular icterus. ATARAX dosage: unknown. During the same period patient was treated with ALDACTAZINE, MECLIZINE, PREDNISONE, IBUPROFEN, TINSET, SECALIP, TIORFAN. Patient was hospitalized. Patient recovered.

ATARAX problem was reported by a Health Professional from FINLAND on Aug 29, 2006. Female patient was diagnosed with pruritus and was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: anger, pyrexia, rash pruritic, vaccination complication. ATARAX dosage: unknown. During the same period patient was treated with MMR II PRO VACCINE, MUMPS VACCINE. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported ATARAX problem on Sept 07, 2006. Male patient, 38 years of age, was diagnosed with pruritus, insomnia and was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: amnesia, dermatitis, gait disturbance, headache, hyperacusis, insomnia, malaise, nausea, pruritus. ATARAX dosage: 75 MG, ORAL. During the same period patient was treated with HALCION, BETAMETHASONE, ALLEGRA, LIVALO, ALLELOCK, ALLOPURINOL, ATELEC, URALYT. Patient was hospitalized. Patient recovered.

ATARAX problem was reported by a Consumer or non-health professional from FRANCE on Sept 08, 2006. Male patient, 66 years of age, was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: intestinal obstruction. ATARAX dosage: 150 MG (25 MG, 6 IN 1 D), ORAL. During the same period patient was treated with LOXAPINE, OLANZAPINE, TIAPRIDE, MACROGOL. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported ATARAX problem on Sept 15, 2006. Male patient, 38 years of age, weighting 169.8 lb, was diagnosed with pruritus, insomnia and was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: amnesia, dermatitis, gait disturbance, headache, hyperacusis, hyperaesthesia, insomnia, malaise, nausea. ATARAX dosage: 75 MG, ORAL. During the same period patient was treated with HALCION, BETAMETHASONE, LIVALO, ALLELOCK, ALLOPURINOL, ATELEC, URALYT, VOLTAREN. Patient was hospitalized. Patient recovered.

ATARAX problem was reported by a Consumer or non-health professional from JAPAN on Sept 12, 2006. Female patient, 86 years of age, was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: choking, dysphagia, hypersomnia, malaise, motor dysfunction. ATARAX dosage: unknown. Patient recovered.

Health Professional from SWEDEN reported ATARAX problem on Sept 25, 2006. Male patient, 45 years of age, was diagnosed with neurosis, depression and was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, diplopia, feeling abnormal, formication, gas poisoning, hyperhidrosis, mental disorder, palpitations, suicide attempt. ATARAX dosage: unknown. During the same period patient was treated with PAROXETINE. Patient was hospitalized. Patient recovered.

ATARAX problem was reported by a Health Professional from FRANCE on Sept 25, 2006. Male patient, 66 years of age, was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: intestinal obstruction, irritability, volvulus. ATARAX dosage: 150 MG (25 MG, 6 IN 1 D) ORAL. During the same period patient was treated with LOXAPINE, OLANZAPINE, TIAPRIDE, MACROGOL. Patient was hospitalized. Patient recovered.

Health Professional from SWEDEN reported ATARAX problem on Sept 25, 2006. Female patient, 41 years of age, was diagnosed with depression and was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: electrocardiogram qt prolonged, nausea, suicide attempt, vomiting. ATARAX dosage: 250 MG, ORAL. During the same period patient was treated with PAROXETINE. Patient was hospitalized. Patient recovered.

ATARAX problem was reported by a Pharmacist from JAPAN on Oct 10, 2006. Male patient, 44 years of age, was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: amnesia. ATARAX dosage: 25 MG, INTRAVENOUS. During the same period patient was treated with SOSEGON. Patient recovered.

Health Professional from FRANCE reported ATARAX problem on Oct 11, 2006. Female patient, 53 years of age, was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: cytolytic hepatitis. ATARAX dosage: 200 MG, ORAL. During the same period patient was treated with LEPTICUR, CLONAZEPAM, TERCIAN, DEPAKOTE. Patient was hospitalized. Patient recovered.

ATARAX problem was reported by a Physician from JAPAN on Oct 11, 2006. Male patient, 68 years of age, weighting 143.3 lb, was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, blood pressure increased, chills, hyperthermia malignant, muscle rigidity, myoglobinuria, post procedural complication. ATARAX dosage: 25 MG (DAY), INTRAMUSCULAR. During the same period patient was treated with ATROPINE SULPHATE, PROPOFOL, VECURONIUM BROMIDE, ROPIVACAINE HYDROCHLORIDE. Patient recovered.

Physician from JAPAN reported ATARAX problem on Oct 17, 2006. Female patient, 81 years of age, was diagnosed with restlessness and was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: respiratory depression. ATARAX dosage: unknown. Patient recovered.

ATARAX problem was reported by a Consumer or non-health professional from JAPAN on Oct 19, 2006. Male patient was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: balance disorder, blister, dizziness, dysuria, erythema, feeling abnormal, hangover, headache, hypoaesthesia. ATARAX dosage: 100 MG, INTRAVENOUS. Patient recovered.

Health Professional from FRANCE reported ATARAX problem on Oct 17, 2006. Male patient, 86 years of age, was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood culture positive, klebsiella infection, sepsis, urinary retention, urinary tract infection. ATARAX dosage: 25 MG, ORAL. During the same period patient was treated with DIGOXIN, SERENOA REPENS, FLUINDIONE, PERINDOPRIL ERBUMINE. Patient was hospitalized. Patient recovered.

ATARAX problem was reported by a Consumer or non-health professional from FRANCE on Oct 17, 2006. Female patient, 71 years of age, was diagnosed with aplastic anaemia, pain in extremity, multiple myeloma and was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: abdominal pain, akinesia, blood pressure diastolic decreased, dilatation ventricular, hot flush, hypothermia, muscle spasms, myocardial infarction, pain in extremity. ATARAX dosage: 37.5 MG, ORAL. During the same period patient was treated with EPOETIN ALFA, HEXAQUINE, LENALIDOMIDE. Patient recovered.

Physician from GERMANY reported ATARAX problem on Oct 16, 2006. Female patient, 39 years of age, was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: fatigue, suicide attempt. ATARAX dosage: unknown. During the same period patient was treated with ALCOHOL, CYMBALTA. Patient recovered.

ATARAX problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 16, 2006. Female patient was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, aggression, amnesia, refusal of treatment by patient, suicidal ideation. ATARAX dosage: 100 MG (1 IN 1 D), ORAL. During the same period patient was treated with AMBIEN. Patient recovered.

Consumer or non-health professional from JAPAN reported ATARAX problem on Oct 23, 2006. Male patient was diagnosed with pain and was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: balance disorder, blister, condition aggravated, dizziness, erythema, feeling abnormal, hangover, headache, hypoaesthesia. ATARAX dosage: 100 MG, INTRAVENOUS. Patient recovered.

ATARAX problem was reported by a Health Professional from FRANCE on Oct 25, 2006. Male patient was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: dysmorphism, feeding disorder neonatal, gingival hypertrophy, high arched palate, hypotonia neonatal, neonatal disorder, retrognathia. ATARAX dosage: unknown. During the same period patient was treated with XANAX, CHLORPROMAZINE, VICTAN. Patient was hospitalized. Patient recovered.

Pharmacist from JAPAN reported ATARAX problem on Oct 27, 2006. Male patient, 59 years of age, was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: muscle atrophy. ATARAX dosage: unknown. During the same period patient was treated with ATROPINE SULPHATE. Patient recovered.

ATARAX problem was reported by a Health Professional from FRANCE on Oct 25, 2006. Male patient, 71 years of age, was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: dehydration, fall, muscular weakness, renal failure. ATARAX dosage: 10 MG (1 D), ORAL. During the same period patient was treated with CARDENSIEL, ZOLPIDEM TARTRATE, DIALGIREX, TAMSULOSIN, ALPRAZOLAM. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported ATARAX problem on Oct 27, 2006. Female patient, 81 years of age, was diagnosed with restlessness and was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: brain stem infarction, cardio-respiratory arrest, heart rate decreased, respiratory depression, respiratory failure. ATARAX dosage: 50 MG (50 MG, ONCE). During the same period patient was treated with LASIX, DORNER, WARFARIN, TICLOPIDINE, DIGOXIN, VERAPAMIL HYDROCHLORIDE, PRAVASTATIN, ZYVOX. Patient died on 10/14/2006.

ATARAX problem was reported by a Pharmacist from JAPAN on Oct 31, 2006. Male patient, 62 years of age, was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: hypoglycaemia, tremor. ATARAX dosage: unknown. During the same period patient was treated with PENTAZOCINE LACTATE, ROPIVACAINE, VOLTAREN, OMEPRAZOLE. Patient recovered.

Physician from JAPAN reported ATARAX problem on Oct 31, 2006. Female patient, 26 years of age, was diagnosed with rhinitis allergic and was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: hepatic function abnormal, malaise, transaminases increased. ATARAX dosage: unknown. During the same period patient was treated with CELTECT. Patient recovered.

ATARAX problem was reported by a Physician from JAPAN on Nov 06, 2006. Male patient, 62 years of age, was diagnosed with procedural pain, infection prophylaxis and was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: hypoglycaemia, muscular weakness. ATARAX dosage: unknown. During the same period patient was treated with VOLTAREN, PENTAZOCINE HYDROCHLORIDE, ROPIVACAINE HYDROCHLORIDE, VANCOMYCIN, OMEPRAZOLE. Patient recovered.

Health Professional from FRANCE reported ATARAX problem on Nov 07, 2006. Female patient, 76 years of age, was diagnosed with lung disorder and was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: blood pressure diastolic decreased, cholestasis, condition aggravated, diabetes mellitus insulin-dependent, fall, iatrogenic injury, lung disorder, pruritus, rash erythematous. ATARAX dosage: 100 MG (1 D), ORAL. During the same period patient was treated with LEVOTHYROXINE, AMOXICILLIN, NOVOMIX, NOVORAPID, RETINOL. Patient was hospitalized. Patient recovered.

ATARAX problem was reported by a Physician from GERMANY on Nov 07, 2006. Female patient, 25 years of age, weighting 141.1 lb, was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: incorrect dose administered, nausea, suicide attempt, vomiting. ATARAX dosage: unknown. During the same period patient was treated with AUGMENTIN, AMOXICILLIN TRIHYDRATE. Patient recovered.

Physician from GERMANY reported ATARAX problem on Oct 25, 2006. Female patient, 39 years of age, was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: fatigue, suicide attempt. ATARAX dosage: unknown. During the same period patient was treated with ALCOHOL, CYMBALTA. Patient was hospitalized. Patient recovered.

ATARAX problem was reported by a Physician from JAPAN on Nov 15, 2006. Male patient, 71 years of age, weighting 136.7 lb, was diagnosed with anaesthesia and was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, autotransfusion, bacterial infection, blood amylase increased, blood lactate dehydrogenase, haemolysis, hepatic function abnormal, hyperthermia malignant. ATARAX dosage: (50 MG), INTRAMUSCULAR. During the same period patient was treated with FENTANYL CITRATE, PROPOFOL, VECURONIUM BROMIDE, NITROUS OXIDE, OXYGEN, SEVOFLURANE. Patient recovered.

Physician from JAPAN reported ATARAX problem on Nov 15, 2006. Female patient, 26 years of age, was diagnosed with rhinitis allergic and was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: hepatic function abnormal, malaise, transaminases increased. ATARAX dosage: unknown. During the same period patient was treated with CELTECT. Patient recovered.

ATARAX problem was reported by a Health Professional from FRANCE on Nov 13, 2006. Female patient, 55 years of age, was diagnosed with schizophrenia, grand mal convulsion and was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: anaemia, c-reactive protein increased, grand mal convulsion, myelodysplastic syndrome, neutropenia, pneumonia legionella. ATARAX dosage: 75 MG (1 IN 1 D) ORAL. During the same period patient was treated with CLOZAPINE, DEPAKENE, GLOBAZAM. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported ATARAX problem on Nov 20, 2006. Male patient, 29 years of age, was diagnosed with dermatitis atopic and was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, rhinorrhoea, salivary hypersecretion. ATARAX dosage: unknown. Patient was hospitalized. Patient recovered.

ATARAX problem was reported by a Physician from JAPAN on Nov 30, 2006. Female patient, 26 years of age, was diagnosed with rhinitis allergic and was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: hepatic function abnormal, liver disorder, malaise, transaminases increased. ATARAX dosage: unknown. During the same period patient was treated with CELTECT. Patient recovered.

Pharmacist from JAPAN reported ATARAX problem on Nov 29, 2006. Male patient, 59 years of age, was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: activities of daily living impaired, gastric polyps, movement disorder, muscle atrophy, pain in extremity. ATARAX dosage: 25 MG, INTRAMUSCULAR. During the same period patient was treated with ATROPINE SULPHATE, HYOSCINE HYT. Patient recovered.

ATARAX problem was reported by a Health Professional from FRANCE on Dec 05, 2006. Female patient, 37 years of age, was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: blood homocysteine increased, pulmonary embolism. ATARAX dosage: 100 MG (100 MG, 1 IN 1 D), ORAL. During the same period patient was treated with DEPAKENE, LEPTICUR, CLONAZEPAM, ZOPICLONE, RISPERDAL. Patient recovered.

Pharmacist from JAPAN reported ATARAX problem on Dec 07, 2006. Male patient, 59 years of age, was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: activities of daily living impaired, movement disorder, muscle atrophy, pain in extremity. ATARAX dosage: 25 MG, INTRAMUSCULAR. During the same period patient was treated with ATROPINE SULPHATE, HYOSCINE HYT. Patient recovered.

ATARAX problem was reported by a Health Professional from FRANCE on Dec 05, 2006. Male patient, 74 years of age, was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: anorexia, blood pressure decreased, fall, head injury, hypoglycaemia, loss of consciousness, spinal fracture, treatment noncompliance. ATARAX dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. During the same period patient was treated with TRAMADOL, LASIX. Patient was hospitalized. Patient recovered.

Health Professional from FRANCE reported ATARAX problem on Dec 15, 2006. Female patient, 45 years of age, was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: cushing's syndrome, urinary retention. ATARAX dosage: DAILY DOSE:400MG. During the same period patient was treated with ABILIFY, NIZORAL, TERCIAN, IMOVANE, ALDACTONE, METOPIRONE, GLUCOPHAGE. Patient was hospitalized. Patient recovered.

ATARAX problem was reported by a Physician from JAPAN on Oct 31, 2006. Female patient, 26 years of age, was diagnosed with rhinitis allergic and was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: hepatic function abnormal, malaise. ATARAX dosage: unknown. During the same period patient was treated with CELTECT. Patient recovered.

Physician from JAPAN reported ATARAX problem on Oct 27, 2006. Male patient, 59 years of age, was treated with ATARAX. After drug was administered, patient experienced the following problems/side effects: muscle atrophy. ATARAX dosage: DAILY DOSE:25MG. During the same period patient was treated with ATROPINE SULPHATE, BUSCOPAN. Patient recovered.

Showing 1-75 of 182 Next >

Ask Our Patient Community about ATARAX
Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions
A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z
This drug has an active FDA Safety Alert
A Abacavir sulfate Abatacept Abilify Acamprosate calcium Accupril Accutane Aceon Aciphex Actiq (fentanyl citrate) Actimmune (aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b) Actonel (risedronate) Actoplus Met (pioglitazone) Actos (pioglitazone) AcuTect (technetium Tc 99m apcitide) Adefovir dipivoxil Advair Diskus(Fluticasone propionate; Salmeterol xinafoate) Adderall (amphetamine salts) Agenerase (amprenavir) Aggrastat (tirofiban) Alamast (pemirolast) Alendronate Alemtuzumab Aleve (naproxen sodium) Alfuzosin Alinia (nitazoxanide) Alimta (pemetrexed) Alitretinoin Almotriptan malate Alosetron hydrochloride Aloxi (palonosetron) Alrex (loteprednol etabonate) Altace (ramipril) Ambien (zolpidem tartrate) Amerge (naratriptan) Aminolevulinic acid Amiodarone Amitiza (lubiprostone) Amnesteem (isotretinoin) Amphadase (hyaluronidase) luronidase) Amphetamine salts Amprenavir Anaprox (naproxen sodium) Angiomax (bivalirudin) Anidulafungin Antagon (ganirelix acetate) Anthelios SX (avobenzone, ecamsule, octocrylene) Apidra (insulin glulisine recombinant) Apokyn (apomorphine) Aprepitant Aprotinin Aptivus (tipranavir) Aranesp (darbepoetin alpha) Arava (leflunomide) Arformoterol Argatroban Aredia (pamidronate) Aripiprazole Arixtra (fondaparinux) Aromasin (exemestane) Arranon (nelarabine) Arsenic trioxide Aspirin Atacand (candesartan cilexetil) Atazanavir sulfate Atomoxetine Avastin (bevacizumab) Avelox (moxifloxacin) Avobenzone, Ecamsule, Octocrylene Avodart (dutasteride) Avonex (interferon beta-1a) Axert (almotriptan malate) Azacitidine Azilect (rasagiline) Azopt (brinzolamide) back to top B Balsalazide disodium Baraclude (entecavir) Benazepril Benicar (olmesartan medoxomil) Bevacizumab Bexarotene Bextra (valdecoxib) Biaxin (clarithromycin) Bimatoprost Bivalirudin Boniva (ibandronate) Bortezomib Brinzolamide Brovana (arformoterol) Bupropion Butisol sodium Byetta (exenatide) back to top C Calfactant Campath (alemtuzumab) Campral (acamprosate calcium) Cancidas (caspofungin) Candesartan cilexetil Capecitabine Capoten (captopril) Captopril Carbamazepine Carbatrol (carbamazepine) Carbrital (pentobarbital and carbromal) Caspofungin Cefditoren pivoxil Cefepime Ceftriaxone Celebrex (celecoxib) Celecoxib Celexa (citalopram hydrobromide) Cetrorelix acetate Cetrotide (cetrorelix acetate) Cetuximab Cevimeline Chantix (varenicline) Cialis (tadalafil) Cilostazol Cinacalcet Cirlesonide Citalopram Claravis (isotretinoin) Clarithromycin Clarinex (desloratadine) Clolar (clofarabine) Clofarabine Clozapine Clozaril (clozapine) Codeine Colazal (balsalazide disodium) Colesevelam Colistimethate Coly-Mycin M (colistimethate) Comtan (entacapone) Concerta (methylphenidate) Conivaptan Cordarone (amiodarone) Crestor (rosuvastatin calcium) Cubicin (daptomycin) Curosurf (poractant alfa) Cylert (pemoline) Cymbalta (duloxetine) Cytotec (misoprostol) back to top D Dacogen (decitabine) Dalfopristin Dalmane (flurazepam) Daptomycin Darbepoetin alpha Darifenacin Darunavir Dasatinib Daytrana (methylphenidate transdermal) DDAVP (desmopressin) DDAVP Nasal Spray (demopressin) DDAVP Rhinal Tube (desmopressin) DDVP (desmopressin Decitabine Deferasirox Definity (perflutren lipid microspheres) Depacon (valproate) Depakene (valproate) Depakote (valproate) Desloratadine Desmopressin Detrol (tolterodine tartrate) terodine tartrate) Dexedrine (dextroamphetamine sulfate) Dexmedetomidine Dexmethylphenidate HCl > Dextroamphetamine sulfate Diastat AcuDial Diazepam rectal gel Didronel (etidronate) Diprivan (propofol) Dofetilide Doral (quazepam) Doxercalcif Drospirenone Duloxetine Duragesic (fentanyl transdermal system) Dutasteride back to top E Eculizumab Edetate disodium Efalizumab Efavirenz Effexor (venlafaxine) Elestat (epinastine) Eletriptan Elidel (pimecrolimus) Ellence (epirubicin) Eloxatin (oxaliplatin) Emend (aprepitant) Emtricitabine Emtriva (emtricitabine) Enablex (darifenacin) Enalapril / Enalaprilat Endrate (edetate disodium) Enfuvirtide Entacapone Entecavir Epinastine Epirubicin Eplerenone Epoetin alfa Epogen (epoetin alfa) Eptifibatide Equetro (carbamazepine) Eraxis (anidulafungin) Erbitux (cetuximab) Ertaczo (sertaconazole) Escitalopram Estazolam Eszopiclone Ethchlorvynol Ethinyl estradiol Etidronate Evoxac (cevimeline) Exelon (rivastigmine tartrate) Exenatide Exjade (deferasirox) Exemestane Extraneal (icodextrin) Ezetimibe Ezetimibe/simvastatin back to top	F Factive (gemifloxacin mesylate) Faslodex (fulvestrant) Felbamate Felbatol (felbamate) Fentanyl buccal tablets Fentanyl citrate Fentanyl transdermal system Fentora (fentanyl buccal tablets) Ferrlecit (sodium ferric gluconate complex) Fleet Accu-Prep (sodium phosphate) Fleet Phospho-Soda (sodium phosphate) Fluoxetine Flurazepam Fluticasone propionate Fluvoxamine Focalin (dexmethylphenidate) Focalin XR (dexmethylphenidate) Fomivirsen Fondaparinux Foradil (formoterol fumarate) Formoterol fumarate Fosamax (alendronate) Fosinopril Frova (frovatriptan succinate) Frovatriptan succinate Fulvestrant Fuzeon (enfuvirtide) G Gabapentin Gabitril (tiagabine) Gadobenate Dimeglumine Gadodiamide Gadolinium Gadopentetate Dimeglumine Gadoteridol Gadoversetamide Galantamine Ganirelix acetate Gatifloxacin Gefitinib Gemifloxacin mesylate Gemtuzumab ozogamicin Geodon (ziprasidone) Gleevec (imatinib mesylate) back to top H Halcion (triazolam) Haldol (haloperidol) Haloperidol Hectorol (doxercalcif) Hepsera (adefovir dipivoxil) Hyaluronidase Hydase (hyaluronidase) Human Secretin back to top I Ibandronate Ibuprofen Icodextrin Iloprost Imatinib mesylate Increlex (Mecasermin [rDNA origin] Infasurf Preservative Free (calfactant) Imitrex (sumatriptan) Innohep (tinzaparin) Inspra (eplerenone) Insulin Aspart recombinant Insulin Detemir recombinant Insulin Glargine recombinant Insulin Glulisine recombinant Intron A (interferon alfa-2b) Integrilin (eptifibatide) ifibatide) Interferon alfa-2b Interferon beta-1a Interferon gamma-1b Invega (paliperidone) Iplex  (mecasermin rinfabate) Iressa (gefitinib) Isotretinoin back to top J Januvia (sitagliptin phosphate) back to top K Kaletra (lopinavir; ritonavir) Kepivance (palifermin) Keppra (levetiracetam) Ketek (telithromycin) Ketotifen fumarate back to top L Lamictal (lamotrigine) Lamotrigine Lantus (insulin glargine recombinant) Leflunomide Lenalidomide Lepirudin recombinant Levalbuterol Levemir (insulin detemir recombinant) Levetiracetam Levitra (vardenafil) Levonorgestrel Levothyroxine sodium Levulan Kerastick (aminolevulinic acid) Lexapro (escitalopram) Lindane Linezolid Lisinopril Lopinavir/ritonavir Lotemax (loteprednol etabonate) Lotensin (benazepril) Loteprednol etabonate Lotronex (alosetron hydrochloride) Lubiprostone Lucentis (ranibizumab) Lumigan (bimatoprost) Lunestra (eszopiclone) Lyrica (pregabalin) back to top M Macugen (pegaptanib) Magnevist (gadopentetate dimeglumine) Maraviroc Mavik (trandolapril) Maxalt (rizatriptan benzoate) Maxipime (cefepime) Mecasermin [rDNA origin] Mecasermin-rinfabate Meloxicam Memantine Metadate CD (methylphenidate HCl) ylphenidate HCl) Methylphenidate HCl Methylphenidate transdermal Mequinol Micafungin Micardis (telmisartan) misartan) Mifeprex (mifepristone) Mifepristone Miglustat Minirin (desmopressin) Mirtazapine Misoprostol Mobic (meloxicam) Modafinil Moexipril Monopril (fosinopril) Moxifloxacin MultiHance (gadobenate dimeglumine) Mycamine (micafungin) Mylotarg (gemtuzumab ozogamicin) back to top N Namenda (memantine) Naprosyn (naproxen) Naproxen Naratriptan Nesiritide recombinant Nateglinide Natrecor (nesiritide recombinant) Nefazodone Nelarabine NeoTect Kit (technetium Tc 99m depreotide) Nesiritide recombinant Neurontin (gabapentin) Nexavar (sorafenib) Nitazoxanide Nitisinone Norelgestromin NovoLog (insulin aspart recombinant) Noxafil (posaconazole) back to top O Olanzapine Olanzapine/fluoxetine Olmesartan medoxomil Omacor (omega-3-acid ethyl esters) Omalizumab Omega-3-acid ethyl esters Omnaris (cirlesonide) Omniscan (gadodiamide) OptiMARK (gadoversetamide) Optison (perflutren protein-type A microspheres) Orencia (abatacept) Orfadin (nitisinone) Orlistat Ortho Evra (norelgestromin; ethinyl estradiol) Oseltamivir phosphate Osmoprep (sodium phosphate) Oxaliplatin Oxcarbazepine back to top P Pacerone (amiodarone) Palifermin Paliperidone